CIK 0001326205
- Non-accelerated filer
- Smaller reporting company
IGC Pharma, Inc.
Sign in to watch- Ticker
- IGC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MD
- Entity type
- Operating
- EIN
- 202760393
- Phone
- +1 301-529-4996
- Business address
- 10224 FALLS ROAD, POTOMAC, MD, 20854
- Former names
- India Globalization Capital, Inc.
- 4 Grant or award Director acquired 300,000 shares (grant or award)
- 4 Grant or award CEO acquired 0 shares (grant or award)
- 4 Grant or award Vice President & PFO acquired 250,000 shares (grant or award)
- 3/A Insider 3/A
- 4/A Grant or award CEO acquired 1,050,000 shares (grant or award)
- 5/A Insider Annual Insider Trading Report
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Senior Director of Finance&PAO acquired 75,000 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 4 Grant or award Director acquired 300,000 shares (grant or award)
- 4 Grant or award CEO acquired 1,050,000 shares (grant or award)
- 4 Open-market sale Director sold 50,000 shares at $1.75 ($87,500)
- 4 Open-market sale Director sold 50,000 shares at an average $1.80 ($90,005)
- 4 Open-market sale Exec. Chairman & CEO sold 50,000 shares at $2.14 ($107,000)
- 4 Open-market sale Director sold 50,000 shares at $2.04 ($102,000)
- 4 Open-market sale Exec. Chairman & CEO sold 80,000 shares at $2.34 ($187,024)
- 5/A Insider Annual Insider Trading Report
- 5/A Insider Annual Insider Trading Report
- 5/A Insider Annual Insider Trading Report
- 4 Grant or award Manager and PAO acquired 30,000 shares (grant or award)
Page 3 of 8 · 156 filings